A novel serum marker, total prostate secretory protein of 94 amino acids, improves prostate cancer detection and helps identify high grade cancers at diagnosis

Journal of Urology

Volumn 175, Issue 4, 2006, Pages 1291-1297

  Nam, Robert K ^a   Reeves, Jonathan R ^b   Toi, Ants ^b   Dulude, Helene ^b   Trachtenberg, John ^b   Emami, Marjan ^b   Daigneault, Luc ^b   Panchal, Chandra ^b   Sugar, Linda ^b   Jewett, Michael A S ^b   Narod, Steven A ^b  

^a Division of Urology   (Canada)

^b NONE

Author keywords

Biological markers; Biopsy; Prostatic neoplasms

Indexed keywords

AMINO ACID; BETA MICROSEMINOPROTEIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER RISK; CONTROLLED STUDY; ENZYME IMMUNOASSAY; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FOLLICLE STIMULATING HORMONE; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; PROSTATIC SECRETORY PROTEINS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 33644599726     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)00695-6     Document Type: Article

References (20)

1. A. von Eschenbach, R. Ho, G.P. Murphy, M. Cunningham, N. Lins American Cancer Society guidelines for the early detection of prostate cancer update, June 10, 1997 Cancer 80 1997 1805
2. T.A. Stamey, N. Yang, A.R. Hay, J.E. McNeal, F.S. Freiha, E. Redwine Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate N Engl J Med 317 1987 909
3. I.M. Thompson, D.K. Pauler, P.J. Goodman, C.M. Tangen, M.S. Lucia, H.L. Parnes Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter N Engl J Med 350 2004 2239
4. T.A. Stamey, M. Caldwell, J.E. McNeal, R. Nolley, M. Hemenez, J. Downs The prostate specific antigen era in the United States is over for prostate cancer what happened in the last 20 years? J Urol 172 2004 1297
5. A.W. Partin, M.K. Brawer, G. Bartsch, W. Horninger, S.S. Taneja, H. Lepor Complexed prostate specific antigen improves specificity for prostate cancer detection results of a prospective multicenter clinical trial J Urol 170 2003 1787
6. W.J. Catalona, G. Bartsch, H.G. Rittenhouse, C.L. Evans, H.J. Linton, W. Horninger Serum pro-prostate specific antigen preferentially detects aggressive prostate cancers in men with 2 to 4 ng/ml prostate specific antigen J Urol 171 2004 2239
7. R.K. Nam, W.W. Zhang, J. Trachtenberg, E.P. Diamandis, A. Toi, M. Emami Single nucleotide polymorphism of the human kallikrein-2 gene highly correlates with serum human kallikrein-2 levels and in combination enhances prostate cancer detection J Clin Oncol 21 2003 2312
8. J.R. Reeves, J.W. Xuan, K. Arfanis, C. Morin, S.V. Garde, M.T. Ruiz Identification, purification and characterization of a novel human blood protein with binding affinity for prostate secretory protein of 94 amino acids Biochem J 385 2005 105
9. D. Wu, Y. Guo, A.F. Chambers, J.I. Izawa, J.L. Chin, J.W. Xuan Serum bound forms of PSP94 (prostate secretory protein of 94 amino acids) in prostate cancer patients J Cell Biochem 76 1999 71
10. S.V. Garde, V.S. Basrur, L. Li, M.A. Finkelman, A. Krishan, L. Wellham Prostate secretory protein (PSP94) suppresses the growth of androgen-independent prostate cancer cell line (PC3) and xenografts by inducing apoptosis Prostate 38 1999 118
11. N. Shukeir, A. Arakelian, S. Kadhim, S. Garde, S.A. Rabbani Prostate secretory protein PSP-94 decreases tumor growth and hypercalcemia of malignancy in a syngenic in vivo model of prostate cancer Cancer Res 63 2003 2072
12. A.Y. Liu, R.C. Bradner, R.L. Vessella Decreased expression of prostatic secretory protein PSP94 in prostate cancer Cancer Lett 74 1993 91
13. B.L. Lokeshwar, K.S. Hurkadli, A.R. Sheth, N.L. Block Human prostatic inhibin suppresses tumor growth and inhibits clonogenic cell survival of a model prostatic adenocarcinoma, the Dunning R3327G rat tumor Cancer Res 53 1993 4855
14. W.A. Sakr, D.J. Grignon, G.P. Haas, L.K. Heilbrun, J.E. Pontes, J.D. Crissman Age and racial distribution of prosatic intraepithelial neoplasia Eur Urol 30 1996 138
15. J. Kwong, K. Lui, P.S. Chan, S.M. Ho, Y.C. Wong, J.W. Xuan Expression study of three secretory proteins (prostatic secretory protein of 94 amino acids, probasin, and seminal vesicle secretion II) in dysplastic and neoplastic rat prostates Prostate 56 2003 81
16. C.L. Huang, D. Brassil, M. Rozzell, P.F. Schellhammer, G.L. Wright Jr Comparison of prostate secretory protein with prostate specific antigen and prostatic acid phosphatase as a serum biomarker for diagnosis and monitoring patients with prostate carcinoma Prostate 23 1993 201
17. P.A. Abrahamsson, H. Lilja, S. Falkmer, L.B. Wadstrom Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands Prostate 12 1988 39
18. M. Pollak, W. Beamer, J.C. Zhang Insulin-like growth factors and prostate cancer Cancer Metastasis Rev 17 1998 383
19. K.S. Hurkadli, B. Lokeshwar, A.R. Sheth, N.L. Block Detection of prostatic-inhibin-like peptide in the cytoplasm of LNCaP cells, a human prostatic adenocarcinoma cell line Prostate 24 1994 285
20. S.V. Garde, A.R. Sheth, A.T. Porter, K.J. Pienta A comparative study on expression of prostatic inhibin peptide, prostate acid phosphatase and prostate specific antigen in androgen independent human and rat prostate carcinoma cell lines Cancer Lett 70 1993 159